New Technology Evaluations
To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.
Sign in | Free Trial | Subscribe | Recommend to Library
New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.
SECTION HEADS
-
Sidney Kimmel Center for Prostate and Urologic Cancer, Sloan Kettering Memorial Cancer Center, New York, NY, USA
-
Clinical Laboratories, Surgery (Urology) and Medicine (GU-Oncology), Memorial Sloan-Kettering Cancer Center, New York, NY, USA
-
Department of Surgery (Urology), University of Toronto, Toronto, ON, Canada
Section Topics
- » Ablative techniques for prostate
- » Ablative techniques for renal masses
- » Drug therapy (including intravesical)
- » New technologies in the diagnosis of urological cancers: molecular markers, genomics & proteomics
- » New technologies in the diagnosis of urological cancers: pathology
- » Robot-assisted surgery
- » Stem cell research
- » Tissue engineering for organ regeneration
- » Vaccine therapy, dendritic cells & immunotherapy
LATEST EVALUATION
Uri Lindner and Alyssa Louis, University Health Network, Princess Margaret Hospital, Canada. F1000 Urology
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
1 Evaluation, most recent by
Damien Bolton, University of Melbourne, Australia. F1000 Urology
- Confirmation
INDIVIDUALS
Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.
Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.
RECOMMENDATIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
LIBRARIANS & INFORMATION MANAGERS
Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.
FREE ACCESS
Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
